FDA product code · Clinical chemistry

Radial Immunodiffusion, Lipoproteins

Name: FDA decisions, review times, recalls and adverse event reports for product code JHP
Creator: 510(k) Report

JHPClass I21 CFR 862.1475510(k) exempt0 decisions0 recalls

FDA lists JHP as exempt from 510(k): a device of this type needs no clearance unless one of the limits in 21 CFR 862.9 applies, such as a new intended use or a different fundamental technology. 0 FDA decisions. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, clinical chemistry panel

Twenty years of JHP at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FIG. 1 — JHP by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in JHP? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 862.1475.

JHQ Nephelometric Method, Lipoproteins MRR System, Test, Low Density, Lipoprotein PYP Low-Density Lipoprotein (Ldl) Cholesterol…JHN Turbidimetric Method, Lipoproteins MSJ Apolipoproteins JHM Colorimetric Method, Lipoproteins MSM System, Test, Lipoprotein (A)JHO Electrophoretic Separation, Lipoproteins LBS Ldl & Vldl Precipitation, Cholesterol Via…JHL Microdensitometry Method, Lipoproteins LBR Ldl & Vldl Precipitation, Hdl LBT Electrophoresis, Cholesterol Via…